Aleš Dudešek

990 total citations
17 papers, 481 citations indexed

About

Aleš Dudešek is a scholar working on Neurology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Aleš Dudešek has authored 17 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Aleš Dudešek's work include Multiple Sclerosis Research Studies (5 papers), RNA regulation and disease (3 papers) and Carbohydrate Chemistry and Synthesis (2 papers). Aleš Dudešek is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), RNA regulation and disease (3 papers) and Carbohydrate Chemistry and Synthesis (2 papers). Aleš Dudešek collaborates with scholars based in Germany, Austria and United Kingdom. Aleš Dudešek's co-authors include Paulus Rommer, Uwe K. Zettl, Matthias Wittstock, Florian Rimmele, R. Benecke, Stephan Kolbaske, Hermann Mascher, Wolfgang Meyer, Tobias Böttcher and Anne‐Katrin Giese and has published in prestigious journals such as PLoS ONE, Neurology and PLoS Genetics.

In The Last Decade

Aleš Dudešek

16 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aleš Dudešek Germany 11 180 177 137 101 96 17 481
Robert L. Conway United States 13 147 0.8× 71 0.4× 338 2.5× 82 0.8× 43 0.4× 23 723
Fabiana Lubieniecki Argentina 14 59 0.3× 100 0.6× 362 2.6× 77 0.8× 126 1.3× 53 651
Carola Hedberg‐Oldfors Sweden 15 83 0.5× 74 0.4× 335 2.4× 40 0.4× 47 0.5× 42 570
Yalda Nilipour Iran 12 71 0.4× 41 0.2× 219 1.6× 30 0.3× 73 0.8× 61 426
Alina Kurolap Israel 12 89 0.5× 52 0.3× 150 1.1× 55 0.5× 36 0.4× 42 399
Raphael Schiffmann United States 9 261 1.4× 56 0.3× 299 2.2× 143 1.4× 13 0.1× 10 539
Go Hun Seo South Korea 11 53 0.3× 48 0.3× 256 1.9× 40 0.4× 31 0.3× 82 527
Adi Mory Israel 15 76 0.4× 78 0.4× 245 1.8× 66 0.7× 43 0.4× 40 592
Olinda Rebelo Portugal 16 44 0.2× 113 0.6× 292 2.1× 26 0.3× 43 0.4× 48 562
Jorge Pinto‐Basto Portugal 11 40 0.2× 55 0.3× 204 1.5× 44 0.4× 115 1.2× 25 414

Countries citing papers authored by Aleš Dudešek

Since Specialization
Citations

This map shows the geographic impact of Aleš Dudešek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleš Dudešek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleš Dudešek more than expected).

Fields of papers citing papers by Aleš Dudešek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleš Dudešek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleš Dudešek. The network helps show where Aleš Dudešek may publish in the future.

Co-authorship network of co-authors of Aleš Dudešek

This figure shows the co-authorship network connecting the top 25 collaborators of Aleš Dudešek. A scholar is included among the top collaborators of Aleš Dudešek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleš Dudešek. Aleš Dudešek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hecker, Michael, Brit Fitzner, Dirk Koczan, et al.. (2024). Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse. Biomedicine & Pharmacotherapy. 175. 116721–116721. 1 indexed citations
2.
Hecker, Michael, Brit Fitzner, Robby Engelmann, et al.. (2023). Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy. Journal of Neuroinflammation. 20(1). 181–181. 8 indexed citations
3.
Hecker, Michael, Brit Fitzner, Alexander Winkelmann, et al.. (2022). Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis. EBioMedicine. 80. 104052–104052. 6 indexed citations
4.
Preuße, Corinna, Andreas Hentschel, Albert Sickmann, et al.. (2022). Endoplasmic reticulum‐stress and unfolded protein response‐activation in immune‐mediated necrotizing myopathy. Brain Pathology. 32(6). e13084–e13084. 12 indexed citations
5.
Walter, Uwe, Reiner Benecke, Dirk Dressler, et al.. (2020). Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy. Neurology. 94(20). e2109–e2120. 35 indexed citations
6.
Faber, Jennifer, Ilaria Giordano, Xueyan Jiang, et al.. (2020). Prominent White Matter Involvement in Multiple System Atrophy of Cerebellar Type. Movement Disorders. 35(5). 816–824. 17 indexed citations
7.
Hecker, Michael, Brit Fitzner, Ina Schröder, et al.. (2019). A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene. PLoS Genetics. 15(2). e1007961–e1007961. 16 indexed citations
8.
Jiang, Xueyan, Jennifer Faber, Ilaria Giordano, et al.. (2019). Characterization of Cerebellar Atrophy and Resting State Functional Connectivity Patterns in Sporadic Adult-Onset Ataxia of Unknown Etiology (SAOA). The Cerebellum. 18(5). 873–881. 6 indexed citations
9.
Walter, Uwe, Aleš Dudešek, & Urban M. Fietzek. (2018). A simplified ultrasonography-guided approach for neurotoxin injection into the obliquus capitis inferior muscle in spasmodic torticollis. Journal of Neural Transmission. 125(7). 1037–1042. 10 indexed citations
10.
Dudešek, Aleš, Florian Rimmele, C. Funke, et al.. (2018). A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia. European Journal of Neurology. 25(7). 943–943. 25 indexed citations
11.
Dudešek, Aleš, et al.. (2016). Autoimmunvermittelte Enzephalomyelitiden: Eine heterogene Krankheitsgruppe zwischen Psychiatrie und Neurologie. Fortschritte der Neurologie · Psychiatrie. 84(S 02). S84–S87.
12.
13.
Rommer, Paulus, et al.. (2013). Monoclonal antibodies in treatment of multiple sclerosis. Clinical & Experimental Immunology. 175(3). 373–384. 40 indexed citations
14.
Dudešek, Aleš, Florian Rimmele, Stephan Kolbaske, et al.. (2013). CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders. Clinical & Experimental Immunology. 175(3). 385–396. 90 indexed citations
15.
Torrás, Joan, Anne‐Katrin Giese, Tobias Böttcher, et al.. (2012). Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene. Clinical Kidney Journal. 5(5). 395–400. 10 indexed citations
16.
Dudešek, Aleš & Uwe K. Zettl. (2006). Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis. Journal of Neurology. 253(S5). v50–v58. 14 indexed citations
17.
Dudešek, Aleš, Wulf Röschinger, Ania C. Muntau, et al.. (2001). Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency. European Journal of Pediatrics. 160(5). 267–276. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026